Featured post

SCS research and awards news

For all our research and awards news, please visit our news page.

Monday, 13 November 2017

Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support

Stephen Opat, EA Hawkes published in the Journal of Clinical Oncology.

Read article here.

No comments:

Post a Comment